| Literature DB >> 31447321 |
Arvin M Gouw1, Katherine Margulis2, Natalie S Liu1, Sudha J Raman3, Anthony Mancuso4, Georgia G Toal1, Ling Tong1, Adriane Mosley1, Annie L Hsieh4, Delaney K Sullivan1, Zachary E Stine4, Brian J Altman4, Almut Schulze3, Chi V Dang5, Richard N Zare6, Dean W Felsher7.
Abstract
Lipid metabolism is frequently perturbed in cancers, but the underlying mechanism is unclear. We present comprehensive evidence that oncogene MYC, in collaboration with transcription factor sterol-regulated element-binding protein (SREBP1), regulates lipogenesis to promote tumorigenesis. We used human and mouse tumor-derived cell lines, tumor xenografts, and four conditional transgenic mouse models of MYC-induced tumors to show that MYC regulates lipogenesis genes, enzymes, and metabolites. We found that MYC induces SREBP1, and they collaborate to activate fatty acid (FA) synthesis and drive FA chain elongation from glucose and glutamine. Further, by employing desorption electrospray ionization mass spectrometry imaging (DESI-MSI), we observed in vivo lipidomic changes upon MYC induction across different cancers, for example, a global increase in glycerophosphoglycerols. After inhibition of FA synthesis, tumorigenesis was blocked, and tumors regressed in both xenograft and primary transgenic mouse models, revealing the vulnerability of MYC-induced tumors to the inhibition of lipogenesis.Entities:
Keywords: ChIP; MYC; MYC conditional transgenic mouse models; RNA-seq; SREBP1; acetyl-CoA carboxylase A inhibition; carbon tracing; fatty acid synthesis; glycerophosphoglycerols; mass spectrometry imaging; nuclear run-on
Mesh：
Substances：
Year: 2019 PMID： 31447321 PMCID： PMC6911354 DOI： 10.1016/j.cmet.2019.07.012
Source DB: PubMed Journal: Cell Metab ISSN： 1550-4131 Impact factor: 27.287